Spending on GLP-1 drugs continues to rise, after outpacing trends among specialty drugs for the first time in 2023, according ...

GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending ...

The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey ...

“Alto helps our partners elevate the patient experience, improve medication access and set new standards for convenience, ...

Several years ago, Sarah Marche, senior vice president of pharmacy services at Highmark, began to question the “legacy way” health plans were managing specialty drugs, which was through ...